3rd Quarter - Report

THE MCMANUS GROUP for ALLERGAN INC

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Opposition to medical device industry tax in S. ____, "America's Healthy Future Act."

LobbyistCovered position, as disclosed
JOHN MCMANUS —
NICK SHIPLEY Legislative Director, Rep. Jay Inslee

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Follow-on biologics provisions in H.R. 3200, "America's Affordable Health Choices Act of 2009" and S. ____, "America's Healthy Future Act." Support for H.R. 1548, "Pathway for Biosimilars Act." Opposition to H.R. 1427, "Promoting Innovation and Access to Life-Saving Medicine Act." Issues related to obesity assessment and treatment.

LobbyistCovered position, as disclosed
JOHN MCMANUS —
NICK SHIPLEY Legislative Director, Rep. Jay Inslee

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1427 (111th), H.R. 3200 (111th), H.R. 1548 (111th)

Medicare/Medicaid MMM

Implementation of the Medicaid drug rebate program. Opposition to Medicare rebates in S. ____, "America's Healthy Future Act," and H.R. 3200, "America's Affordable Health Choices Act of 2009."

LobbyistCovered position, as disclosed
JOHN MCMANUS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3200 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.